Close Menu

Huntington's disease

The partners will develop biomarkers for potential use in drug development targeting the disease. 

The deal does not cover Voyager's fledgling effort to use RNAi to treat amyotrophic lateral sclerosis.

The panel may prove useful in clinical trials of drugs interfering with mutant gene expression, the researchers said.

NEW YORK (GenomeWeb) – PerkinElmer said in its Form 10-Q that it reduced its headcount by 152 employees in the third quarter as a result of a restructuring plan. It also took a pre-tax restructuring charge of $13.2 million in the quarter related to the workforce reduction.

NEW YORK (GenomeWeb News) – Evotec said today that the CHDI Foundation has extended and expanded the two parties' collaboration on Huntington's disease research through 2017.

NEW YORK (GenomeWeb) – The Structural Genomics Consortium and the CHDI Foundation have struck an agreement to discover and characterize new drug targets for Huntington's disease and to make their findings available for use by academic researchers and pharmaceutical and biotechnology companies.

NEW YORK (GenomeWeb) – Researchers from Genzyme this month reported new proof-of-concept data showing that an expressed RNAi approach could be used to both prevent and treat the manifestations of Huntington's disease (HD) in an animal model of the condition.

NEW YORK (GenomeWeb News) – KineMed said this week that it has extended its collaboration with the CHDI Foundation on research into biomarkers for Huntington's disease.

NEW YORK (GenomeWeb) – KineMed and CHDI Foundation today said they are extending their collaboration to characterize and track the pathogenesis of Huntington's disease and to evaluate possible therapeutic interventions.

NEW YORK (GenomeWeb News) – The Coriell Institute for Medical Research recently announced a $7.7 million contract extension from the National Institute for Neurological Disorders and Stroke to maintain the institute's biobank.

Pages

Nebula Genomics will be auctioning George Church's genome as a nonfungible token, according to The Scientist.

Anthony Gregg, the outgoing president of the American College of Medical Genetics and Genomics, has resigned after using racially insensitive language. 

Facebook has developed an artificial intelligence approach to predict how drugs interact in cells, New Scientist reports.

In PNAS this week: adaptations among high-altitude Mycobacterium tuberculosis, response of multiple myeloma cells to chemotherapy-induced stress, and more.